Aura Biosciences, Inc. (AURA) vs CytomX Therapeutics, Inc. (CTMX)
Aura Biosciences, Inc. and CytomX Therapeutics, Inc. are both Biotechnology companies. Aura Biosciences, Inc. and CytomX Therapeutics, Inc. are of similar size ($637.8M and $599.2M). Aura Biosciences, Inc. has the higher net margin (0.00% vs −451.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Aura Biosciences, Inc. leads on 7 and CytomX Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | AURA | CTMX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (476.19%) | 0.00% |
| Net margin | 0.00% | (451.62%) | 0.00% |
| Free cash flow margin | 0.00% | (450.27%) | 0.00% |
| Return on equity | (53.49%) | (39.18%) | (57.72%) |
| Return on assets | (47.42%) | (29.72%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack